Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer.
Reck M, Luft A, Bondarenko I, Shevnia S, Trukhin D, Kovalenko NV, Vacharadze K, Andrea F, Hontsa A, Choi J, Shin D. Reck M, et al. Lung Cancer. 2020 Aug;146:12-18. doi: 10.1016/j.lungcan.2020.05.027. Epub 2020 May 28. Lung Cancer. 2020. PMID: 32502923 Free article. Clinical Trial.
Carboplatin in small cell lung cancer.
Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1991 Feb;18(1 Suppl 2):8-16. Semin Oncol. 1991. PMID: 1846981 Clinical Trial.
Chemotherapy in stage-IV NSCLC.
Reck M, Gatzemeier U. Reck M, et al. Lung Cancer. 2004 Aug;45 Suppl 2:S217-22. doi: 10.1016/j.lungcan.2004.07.972. Lung Cancer. 2004. PMID: 15552802 Review.
532 results